AstraZeneca Pharma India Ltd. — Board/Management Information 2024

Jul 3, 2024

==> picture [490 x 55] intentionally omitted <==

July 3, 2024

The Manager- Listing BSE Limited Corporate Relationship Dept., 5[th] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai – 400 001

The Manager- Listing National Stock Exchange of India Limited Exchange Plaza, 5[th] Floor, Plot No. C/1, G - Block Bandra –Kurla Complex, Bandra (E), Mumbai – 400 051

Dear Sir(s),

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) – Regulations, 2015 Change in role of Senior Management Personnel

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that our current Site Lead India Operation – Ms. Mina Patel is completing her international assignment on July 31, 2024. She will be transitioning from the said role with effect from close of business hours July 31, 2024, as she takes up another responsibility within AstraZeneca group.

Further, we wish to inform that, based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company have approved the appointment of Mr. Srikanth B.S. as Site Lead, India Operations with effect from August 1, 2024.

In this regard, please find the details as required under the SEBI Circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 attached herewith as Annexure – A .

Kindly take the above information on record.

For AstraZeneca Pharma India Limited

Digitally signed MANAS by MANASA RAMA A RAMA Date: 2024.07.03 11:04:01 +05'30'

Manasa. R Company Secretary

==> picture [453 x 64] intentionally omitted <==

==> picture [490 x 55] intentionally omitted <==

Annexure - A

Sl.	Particulars	Details
No
1	Reason for change viz. appointment, resignation, removal, death or otherwise;	Appointment of Mr. Srikanth B.S. as Site Lead, India Operations
2	Date of appointment/ cessation (as applicable) and term of appointment	Effective August 1, 2024 Term of appointment – Full – time employement
3	Brief Profile	Mr. Srikanth is an Industrial engineer with master’s diploma in Business administration with over 27 years of experience. He has wealth of experience from companies like Dr. Reddy’s and GE. He has served AstraZeneca for over 23 years and has worked in multiple functions with experience in areas of procurement, production, planning, product outsourcing, Distribution, new product introduction and ERP implementation with thorough understanding of the concepts of integrated supply chain. He has led and transformed the supply chain function to ensure timely supplies with zero stock outs, led successful CFA optimization projects across distribution network and improved compliance across the entire supply chain and has also managed multiple product switches from AstraZeneca global sites into India operations.
4	Disclosure of relationships between directors	Not Applicable

==> picture [453 x 64] intentionally omitted <==